Clinical Trial Update: Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial update on bedtime versus morning dosing of ACEIs/ARBs for reverting non-dipping hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Non-dipping Hypertension

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Hypertension, Non-Dipping | Phase 4 | Status: TERMINATED